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Abstract
Background:  Cancer  of  the  head  and  neck  comprises  a  group  of  neoplasms  that  share  a  simi-
lar anatomical  origin.  Most  originate  from  the  epithelium  of  the  aerodigestive  tract  and  90%
correspond to  squamous  cell  carcinoma.  In  the  last  15  years,  an  increase  in  the  incidence  of
squamous cell  carcinoma  induced  by  human  papillomavirus  (HPV)  has  been  seen,  mainly  types
16 and  18,  which  are  the  most  frequent  found  in  cancers  of  the  oral  cavity  and  oropharynx,
and types  6  and  11  in  laryngeal  cancer.  There  are  reports  in  the  literature  that  show  HPV  as  the
leading cause  of  oropharyngeal  squamous  cell  carcinoma.
Objective:  Determine  the  prevalence  of  infection  with  high-risk  HPV  in  patients  diagnosed  with
squamous  cell  carcinoma  of  the  oral  cavity,  oropharynx  and  larynx.
Material  and  methods:  An  observational,  cross-sectional,  descriptive,  unblinded  study  was  per-
formed. Prevalence  of  HPV  infection  was  determined  by  polymerase  chain  reaction  (PCR)  in
DNA samples  from  tumour  tissue  of  patients  with  squamous  cell  carcinoma  of  the  oral  cavity,
oropharynx  and  larynx.  Typing  was  subsequently  performed  in  HPV  positive  samples  in  order  to
detect types  18,  16,  11  and  6,  using  custom  primers.
 Please cite this article as: Villagómez-Ortíz VJ, Paz-Delgadillo DE, Marino-Martínez I, Cesen˜as-Falcón LÁ, Sandoval-de la Fuente A, Reyes-
Escobedo A. Prevalencia de infección por virus del papiloma humano en carcinoma espinocelular de cavidad oral, orofaringe y laringe. Cir
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Results:  A  total  of  45  patients  were  included.  The  association  between  laryngeal  squamous  cell
carcinoma and  HPV  was  established  in  two  patients,  which  represented  an  overall  prevalence
of 4.4%  in  our  population,  and  10%  for  laringeal  tumours.
Conclusions:  There  is  a  low  prevalence  of  HPV  infection  in  squamous  cell  carcinoma  of  the  oral
cavity, oropharynx  and  larynx,  in  our  population.  Prospective  studies  on  younger  patients  could
provide more  information.
©  2016  Academia  Mexicana  de  Cirug´ıa  A.C.  Published  by  Masson  Doyma  Me´xico  S.A.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Prevalencia  de  infección  por  virus  del  papiloma  humano  en  carcinoma  espinocelular
de  cavidad  oral,  orofaringe  y  laringe
Resumen
Antecedentes:  El  carcinoma  de  cabeza  y  cuello  comprende  un  grupo  de  neoplasias  que  com-
parten un  origen  anatómico  similar.  La  mayoría  se  originan  de  la  mucosa  del  tracto  aerodigestivo
y más  del  90%  corresponden  al  carcinoma  espinocelular.  En  los  últimos  15  an˜os  se  observó  un
incremento  en  la  incidencia  de  carcinoma  espinocelular  inducido  por  el  virus  del  papiloma
humano (VPH)  en  jóvenes,  principalmente  los  serotipos  16  y  18,  los  cuales  son  los  más  estu-
diados en  cáncer  de  cavidad  oral  y  orofaringe,  y  los  serotipos  6  y  11  en  cáncer  de  laringe.
Existen reportes  en  la  literatura  sobre  el  VPH  como  principal  causa  de  carcinoma  espinocelular,
principalmente  de  orofaringe.
Objetivo:  Determinar  la  prevalencia  de  infección  por  VPH  de  alto  riesgo  en  pacientes  con
diagnóstico  de  carcinoma  espinocelular  de  cavidad  oral,  orofaringe  y  laringe.
Material  y  métodos:  Estudio  observacional,  transversal,  descriptivo,  no  ciego.  Se  determinó
la prevalencia  de  infección  por  VPH  por  medio  de  la  reacción  en  cadena  de  la  polimerasa  en
muestras de  ADN  de  tejido  tumoral  en  pacientes  con  carcinoma  espinocelular  de  cavidad  oral,
orofaringe  y  laringe.  Se  realizó  tipiﬁcación  de  serotipos  de  alto  riesgo.
Resultados:  Se  incluyó  en  el  estudio  un  total  de  45  pacientes.  La  asociación  entre  el  carci-
noma de  células  escamosas  de  laringe  con  VPH  se  ailo  en  2  pacientes,  lo  cual  represento  una
prevalencia  global  del  4.4%  en  nuestra  población  y  del  10%  para  los  tumores  de  laringe.
Conclusiones:  Existe  una  baja  prevalencia  de  carcinoma  espinocelular  de  la  cavidad  oral,  oro-
faringe y  laringe,  asociado  a  infección  por  VPH  en  nuestra  población.  Estudios  prospectivos  en
población más  joven  con  cáncer  de  cabeza  y  cuello  podrían  aportar  mayor  información  sobre
la inﬂuencia  del  VPH  en  dicha  patología.
© 2016  Academia  Mexicana  de  Cirug´ıa  A.C.  Publicado  por  Masson  Doyma  Me´xico  S.A.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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ancer  of  the  head  and  neck  comprises  a  group  of  neo-
lasms  that  share  a  similar  anatomical  origin.  Most  originate
rom  the  mucous  membrane  encasing  the  epithelium  of  the
erodigestive  tract  and  over  90%  correspond  to  squamous
ell  carcinoma.  They  rank  sixth  in  worldwide  neoplasms  of
ll  locations  and  the  most  commonly  affected  site  is  the  oral
avity.1
It  has  been  calculated  that  approximately  400,000  new
ases  per  year  are  diagnosed  worldwide,  with  higher  preva-
ence  in  males.  The  most  common  sites  of  origin  are  the
ral  cavity  and  the  oropharynx.  In  the  oral  cavity  the  most
ffected  area  is  the  tongue,  followed  by  the  gums  and  the
oor  of  the  mouth.  In  the  oropharynx  it  is  the  tonsillar
egión.2
In  Mexico,  5%  of  all  malignancies  correspond  to  the
pidermoid  carcinoma  of  the  head  and  neck,  which  in
h
s
peneral  is  diagnosed  in  advanced  stages,  particularly  in  the
ongue.3
Several  mechanisms  have  been  reported  in  the  genesis  of
umours  which  originate  in  the  upper  aerodigestive  tracts,
ith  the  most  outstanding  being  the  carcinogenic  effects  of
lcohol  and  tobacco  as  the  main  risk  factors  and  which  play  a
ajor  role  in  their  aetiopathogenesis  due  to  their  potential
o  induce  mutations  in  tumour  suppressor  gene  p53.4
However,  the  role  of  the  human  papillomavirus  has  now
een  recognised  as  an  independent  factor  in  the  devel-
pment  of  these  neoplasms.  During  the  last  15  years  an
ncrease  in  the  incidence  of  squamous  cell  carcinoma
nduced  by  the  human  papillomavirus  (HPV)  has  been
bserved,  with  its  frequency  increasing  in  young  patients
nd  in  non  smokers  or  drinkers,  especially  associated  with
igh  risk  serotypes  such  as  viral  16  sub-type.  This  has  been
upported  by  reports  in  the  literature  which  show  HPV  as  the
rimary  cause  of  oropharyngeal  squamous  cell  carcinoma.5,6
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ACCGGTGTTAAGCGCC-3 /5 -TTGGCAGGGCAATGTGTACCTG-
3′,  HPV-11  5′-GCTGTGTCTAAGCCCTCTACAG-3′/5′-GTACCTT-Prevalence  of  human  papillomavirus  infection  in  squamous  c
There  are  over  180  known  viral  sub-types,  of  which  over
40  sub-types  of  HPV  are  sexually  transmitted  and  infect  the
anogenital  tract  and  are  thus  transmitted  to  the  oral  cavity.7
HPV  have  been  classiﬁed  as  high,  intermediate  and  low
risk,  depending  on  their  association  with  malignant  neo-
plasms.  Serotypes  16  and  18  are  considered  high  risk  and
they  are  linked  to  cancer  of  the  oral  cavity  and  oropharynx,
whilst  serotypes  6  and  11  are  considered  low  risk  and  have
been  linked  to  cancer  of  the  larynx.8
The  mechanism  by  which  the  virus  induces  head  and
neck  squamous  cell  carcinoma  is  not  altogether  clear  and  is
subject  to  controversy.  The  potential  oncogenic  for  insert-
ing  speciﬁc  DNA  fragments  (E6  and  E7)  in  the  host  genome
leads  to  suppression  of  tumour  suppressor  factors  p53  or  Rb
and  the  ability  to  induce  dysplastic  lesions  and  malignant
neoplasms.9
The  majority  of  immune  competent  individuals  are  able
to  eliminate  infection  without  any  clinical  signs  and  only
10%  develop  lesions.  The  integration  of  the  DNA  of  the  virus
in  the  host  genome  is  a  predictor  of  the  progression  of  an
infection  to  the  formation  of  a  neoplasm.10
Despite  the  increase  in  the  risk  of  squamous  cell  car-
cinoma  of  the  head  and  neck,  better  prognosis  exists  for
patients  in  whom  the  viral  DNA  is  detected,  and  who  there-
fore  have  greater  control  and  a  better  rate  of  survival.
One  study  conducted  in  the  United  States  in  2010  showed
that  HPV  positive  squamous  cell  carcinoma  presented  a  58%
reduction  in  the  risk  of  death,  whilst  age,  smoking  rates  and
invasion  of  the  lymph  nodes  continue  being  the  determining
factors  in  survival.11
The  aim  of  this  article  is  to  determine  the  prevalence  of
high  risk  HPV  (16,  18)  and  low  risk  HPV  (6,  11)  in  patients
diagnosed  with  squamous  cell  carcinoma  of  the  oral  cavity,
oropharynx  and  larynx.
Material and methods
An  observational,  cross-sectional,  descriptive,  unblinded
study  was  performed  which  included  all  patients  who  had
been  histopathologically  diagnosed  with  squamous  cell  car-
cinoma  of  the  oral  cavity,  oropharynx  and  larynx  who
attended  the  Servicio  de  Otorrinolaringología  y  Cirugía  de
Cabeza  y  Cuello  in  the  Hospital  Universitario  José  Eleu-
terio  González  between  1st  January  2011  and  31st  December
2013.  The  study  included  a  total  of  45  patients.
Patients  of  both  sexes  who  had  been  histopathologically
diagnosed  with  primary  squamous  cell  carcinoma  of  the  head
and  neck  were  included  in  the  study.
Those  patients  with  carcinoma  of  the  oral  cavity,
oropharynx  and  larynx  with  a  different  histological  type  to
squamous  cell  carcinoma  were  excluded,  as  were  patients
under  18  years  of  age  and  patients  who  had  previously
received  radiotherapy  or  chemotherapy.
A  complete  medical  history  of  each  patient  was  con-
ducted  to  search  for  risk  factors  related  to  the  development
of  squamous  cell  carcinoma,  such  as  alcoholism,  a  tobacco
habit,  a  periodontal  disease,  the  presence  of  laryngeal  papil-
lomatosis  or  a  family  history  of  squamous  cell  carcinoma  of
the  head  and  neck.  A  complete  ENT  examination  was  car-
ried  out,  including  examination  with  a  ﬂexible  endoscopy
using  Karl  Storz  RP1® ﬁbre  optic  material  and  the  Endodigi®
G
C
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igitalisation  system.  A  search  for  HPV  genetic  material  was
ade  using  the  polymerase  chain  reaction  technique  at  the
nal  point  of  the  reaction.
DNA  extraction  of  fresh  tumour  tissues  was  performed
n  9  patients,  and  tissue  stored  in  parafﬁn  blocks  was
btained  for  the  other  patients.  Parafﬁn  blocks  of  10  m
hickness  were  obtained,  and  collected  in  1.5  ml  tubes.  The
arafﬁn  was  removed  and  they  were  subsequently  dehy-
rated.  DNA  extraction  was  performed  using  the  proteinase
/phenol  method.  The  DNA  concentration  was  determined
hrough  spectrophotometry  in  the  NanoDrop  2000  (Termo
isher  Scientiﬁc,  Inc.,  Wilmington,  DE)  and  a  quantity  was
xtracted  by  1%  agarose  gel  electrophoresis  in  order  to  visu-
lly  evaluate  its  quality.  For  HPV  detection  the  PCR  end  point
echnique  was  used,  with  the  general  initiators  MY09/MY11
nd  GP5/GP6  for  detection  of  the  L1y  CpI/CpII  region  for
etection  of  gene  E1.  An  Eppendorft  Mastercycler  Gradient
hermal  cycler  (Eppendorf  AG,  Hamburg,  Germany)  was  used
or  the  PCR.
The  presence  of  the  viral  subtypes  6,  11,  16  and  18  were
raced  through  the  positive  samples  for  the  human  papillo-
avirus  using  speciﬁc  HPV  initiators.
NA  sample  and  analysis  from  chain  reaction  of  the
olymerase
he  DNA  was  extracted  from  8  fresh  tumour  samples  of
iopsies  and  36  tumour  biopsies  embedded  in  parafﬁn.
oth  samples  were  extracted  using  the  K/phenol  proto-
ol.  However,  the  parafﬁn  blocks  were  cut  into  10  m
hick  slices  and  deparafﬁnised  with  xylitol  prior  to  the
igestion  of  proteinase  K.  The  DNA  concentration  was
etermined  by  spectrophotometry  using  NanoDrop  2000
Thermo  Fisher  Scientiﬁc,  Inc.,  Wilmington,  DE),  and  a  small
uantity  was  extracted  by  1%  agarose  gel  electrophore-
is  in  order  to  evaluate  its  quality.  For  HPV  detection
he  PCR  end  point  technique  was  used,  with  the  general
nitiators  MY09/MY11  (MY09:  5′-CGTCCMARRGGAWACTGATC-
′,  MY11:  5′-GCMCAGGGWCATAAYAATGG-3′)  and  GP5/GP6
GP5  5′-TTTGTTACTGTGGTAGATACTAC-3′;  GP6  5′-GTAGT-
TCTACCACAGTAACAAA-3′) to  detect  the  viral  gene  L1  and
pI/CPII  (CpI:  TTATCAWATGCCCAYTGTACCAT-3′;  CpII:  5′-G
TGTTAATWSAGCCWCCAAAATT-3′) and  the  initiators  for  the
etection  of  gene  E1.  PCR  was  performed  using  the  Eppen-
orft  Gradient  thermal  cycler  (Eppendorf  AG,  Hamburg,
ermany)  and  GoTaq-GreenMaster  Mix  (PROMEGA,  USA.),  in
ccordance  with  protocols  recommended  by  the  manufac-
uring  company.
Once  the  positive  samples  for  the  HPV  had  been  identiﬁed
y  any  of  the  general  initiators  (MY,  GP  and  CP),the  pres-
nce  of  the  viral  subtypes  6,  11,  16  and  18  were  determined
y  PCR  using  initiators  speciﬁcally  designed  to  identify
 fragment  within  the  viral  genome  of  the  long  region
f  speciﬁc  control  for  said  subtypes  (HPV-6  5′-TATTCGT-
′ ′GCACACAACATAT  GG-3′,  HPV-16  5′-ACCTCATCTACCTCTA-
AACTGC-3′/5′-GGCAAGCAGTGCAGGTC  AGG-3′ y  HPV-18
′-AACCTGCCAAGCGTGTGCGTG  -3′/5′-TAAGCCAAAGGCAA
CGAAATCG-3′).
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Table  1  General  characteristics  of  the  sample  under  study.
Characteristics  Patients  (n  =  45)
Age,  in  years  58  (39--92)
Gender,  n  (%)
Male  32  (71)
Female  13  (29)
Risk factors,  n  (%)
Alcoholism  16  (36)
Smoking  habit  22  (49)
Periodontal  disease  34  (76)
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Figure  2  Distribution  by  clinical  states  of  disease  on  diagno-
sis.
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tatistical  analysis
or  analysis  of  the  sample  characteristics,  descriptive  statis-
ics  using  means  and  ranges  for  continuous  variables  and
ercentages  for  categorical  variables  were  used,  in  addi-
ion  to  the  means  and  standard  deviations  depending  on
he  variables  described.  The  statistical  programme  IBM  SPSS
tatics  version  20.0  was  used  for  the  analysis.
esults
 total  of  45  patients  (32  males  and  13  females)  were
ncluded,  with  a  median  age  of  58.  49%  of  patients  pre-
ented  with  a  history  of  smoking,  36%,  with  a  history  of
lcoholism  and  periodontal  disease  was  found  in  76%  of  the
atients.  The  other  demographic  characteristics  are  shown
n  Table  1.  The  sites  found  were:  larynx  in  19  patients,  rep-
esenting  42.2%;  tongue  in  12  patients;  tonsil  and  lip  in  4
atients  respectively;  ﬂoor  of  the  mouth,  hard  palate  and
lveolar  ridge  in  2  patients  (Fig.  1).  Distribution  by  clinical
isease  stage  on  diagnosis  was:  17  clinical  stage  IV  patients,
1  stage  III  patients,  10  stage  II  and  7  stage  1  patients
Fig.  2).  Infection  by  HPV  was  detected  in  2  patients  (4.4%),
oth  diagnosed  with  cancer  of  the  larynx.  The  viral  sub-
ype  detected  in  both  patients  was  type  11;  Fig.  3  shows
istribution  by  age  group  on  diagnosis  of  the  disease.
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Figure  3  Distribution  by  age  group  on  disease  diagnosis.
iscussion
he  prevalence  of  head  and  neck  cancer  according  to  loca-
ion,  as  described  by  Parkin  et  al.1 in  Globocan  2000,
ighlights  the  oral  cavity  as  the  most  commonly  affected
ite  (50%),  matching  our  results  (57.8%).  Cancer  of  the  lar-
nx  was  detected  in  42.2%  of  our  sample,  unlike  the  32%
eported  by  this  same  study.
In  the  majority  of  our  patients  (62.2%)  an  advanced  clini-
al  stage  was  detected  (stages  III  and  IV);  this  is  reﬂected  in
he  conditions  of  our  sample,  characterised  by  a low  socio-
conomic  level  and  difﬁcult  access  to  specialised  hospital
ervices,  resulting  in  the  disease  advancing  to  later  stages.
Smoking  is  the  key  factor  for  the  development  of  squa-
ous  cell  carcinoma  of  the  head  and  neck.  90%  of  oral  cavity
ancers  in  men  and  60%  in  women  are  attributed  to  the  con-
umption  of  tobacco.12 The  habit  of  placing  tobacco  in  the
ral  mucous  membrane  (under  the  tongue  or  in  the  cheek)
ncreases  the  risk  from  4  to  6  times  of  oral  cavity  cancer  in
ips,  tongue  and  cheek  mucosa.  This  is  an  infrequent  habit
n  Mexico  but  popular  in  several  regions  of  the  United  States
nd  Europe.13 we  did  not  ﬁnd  any  patients  with  this  habit  in
ur  sample.Alcohol  consumption  is  also  associated  with  the  increase
n  the  risk  of  suffering  from  squamous  cell  head  and  neck
arcinoma,  and  is  the  second  most  important  aggressor  after
obacco.  The  risk  of  cancer  in  drinkers  is  6  times  higher  than
ell  c
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in  non  drinkers  and  the  risk  of  death  from  oropharyngeal  can-
cer  is  4  times  greater  in  drinkers.  There  is  therefore  a  strong
relationship  with  squamous  carcinoma  originating  in  the  oral
cavity,  oropharynx,  hypo-pharynx  and  supraglottis.14
Alcohol  and  tobacco  intoxication  is  synergetic  in  the  gen-
esis  of  squamous  cell  carcinoma,  raising  the  relative  risk
sixteenfold  when  they  are  combined.15
In  our  sample  we  observed  a  prevalence  of  35%  drinkers
and  51%  smokers.  There  was  also  a  71%  prevalence  of  can-
cer  in  males,  which  matches  that  described  in  the  literature.
We  know  that  there  is  an  increase  in  the  incidence  of  head
and  neck  cancer  in  females  owing  to  the  increase  in  smok-
ing,  which  increased  from  a  6:1  male/female  ratio  in  the
1960s  to  a  4:1  ratio  at  the  present  time.16,17 In  our  study  the
approximate  male  to  female  ratio  was  3:1.
At  the  beginning  of  the  1980s,  a  little  after  recognition  of
HPV  as  an  aetiological  factor  of  cervical  and  uterine  cancer,
the  participation  of  this  virus  in  cancer  of  the  head  and  neck
was  acknowledged.18
However,  despite  the  efforts  to  lower  the  rate  of  tobacco
usage,  the  development  of  cancer  in  the  oropharynx  and
palatine  tonsils  has  increased  threefold,  both  in  United
States  and  Europe.19,20
Meta-analysis  conducted  in  2008  by  Termine  et  al.21
established  a  34.5%  prevalence  of  the  HPV  in  cancer  of  the
head  and  neck  originating  from  the  oral  cavity,  pharynx  or
larynx.
The  most  frequent  viral  subtypes  in  head  and  neck  cancer
are  16  and  18,  with  their  ability  to  immortalise  the  infected
cell  due  to  oncogenes  E6  and  E7  and  suppression  factors  RB
and  p53.22,23 There  is  proof  in  the  literature  of  a  better  prog-
nosis  for  survival  (33%),  greater  in  patients  with  squamous
cell  carcinoma  with  HPV(+)  status  versus  HPV(−) status.24
Infection  caused  by  HPV  was  detected  in  2  patients
(4.4%),  both  diagnosed  with  cancer  of  the  larynx.  The  viral
sub-type  detected  in  both  patients  was  type  11.  For  the
rest  of  the  tumours  no  association  with  HPV  was  estab-
lished,  which  differs  from  that  reported  in  the  literature.
The  patients  with  HPV  had  a  history  of  laryngeal  papillo-
matosis  with  severe  dysplasia  which  progressed  to  squamous
cell  carcinoma.  The  cancer  of  these  patients  was  detected
at  an  early  stage  (clinical  stages  I  and  II).
The  possible  reasons  for  which  HPV  was  not  isolated  in  the
majority  of  our  sample  may  be  due  to  several  factors:  ﬁrst
the  virus  is  epigenetic  at  the  start  of  the  infection  and  conse-
quently  it  is  possible  to  detect  it  in  cellular  DNA  a  long  time
before  dysplasic  tumours  are  induced.  Once  it  has  integrated
to  the  bone  genome  where  the  changes  in  cellular  morphol-
ogy  have  taken  place  its  detection  is  more  complicated,  as
reported  by  Koskinen  et  al.25 in  a  study  conducted  in  2003.
Another  point  to  consider  is  the  median  age  of  our  patients,
which  was  58,  since  HPV  has  been  generally  isolated  in  a
younger  population.5,6
Conclusion
The  frequency  by  location  of  the  different  squamous  cell
head  and  neck  carcinomas  was  similar  to  that  reported  in
the  literature,  with  the  oral  cavity  predominating  as  the
most  affected  site.  There  was  a  high  incidence  of  typically
mentioned  risk  factors  (smoking,  alcoholism  periodontalarcinoma  367
isease),  with  periodontal  disease  being  the  most  commonly
ound.  HPV  was  only  isolated  in  4.4%  of  our  patients.  How-
ver,  the  median  age  of  the  sample  studies  was  high  and  HPV
as  isolated  in  the  youngest  sample  diagnosed  with  head  and
eck  carcinoma.  For  a  more  precise  clariﬁcation  of  the  role
f  this  virus  in  this  disease  it  is  therefore  important  to  carry
ut  prospective  studies  in  minors.
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